Elutia (ELUT) Notes Payables (2019 - 2025)

Elutia (ELUT) posted Notes Payables of $5.0 million for Q3 2025, up 33.33% sequentially from $3.8 million in Q2 2025.

Elutia (ELUT) Notes Payables (2019 - 2025) Analysis & Trends

Elutia has reported Notes Payables for 7 years, with the latest figure at $5.0 million in Q3 2025.

Quarterly Notes Payables changed N/A year-over-year to $5.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $5.0 million (changed N/A YoY) and the FY2024 annual result came in at $1.2 million, down 62.36% from the prior year.
Notes Payables improved to $5.0 million in Q3 2025 per ELUT's latest filing, from $3.8 million in the prior quarter.
Over five years, Notes Payables peaked at $8.6 million in Q1 2021 and troughed at $1.2 million in Q4 2024.
A 5-year average of $5.4 million and a median of $5.0 million in 2025 frame the typical range for Notes Payables.
The sharpest annual moves came in 2021 and 2024: Notes Payables surged 178.86% in 2021, then sank 62.36% in 2024.
Over 5 years, Notes Payables stood at $8.1 million in 2021, then changed by 0.0% to $8.1 million in 2022, then tumbled by 58.79% to $3.3 million in 2023, then sank by 62.36% to $1.2 million in 2024, then jumped by 300.0% to $5.0 million in 2025.
According to Business Quant data, Notes Payables over the past three periods registered $5.0 million, $3.8 million, and $2.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	200.06 Bn	194.46 Bn	7.27 Bn
2	Stryker	125.96 Bn	122.48 Bn	4.50 Bn
3	Medtronic	118.37 Bn	109.15 Bn	6.41 Bn
4	Boston Scientific	73.05 Bn	72.51 Bn	3.85 Bn
5	Edwards Lifesciences	51.54 Bn	47.29 Bn	1.35 Bn
6	Dexcom	34.43 Bn	32.48 Bn	830.00 Mn
7	GE HealthCare Technologies	33.65 Bn	31.54 Bn	2.18 Bn
8	Koninklijke Philips	26.11 Bn	22.79 Bn	4.55 Bn
9	Steris	23.11 Bn	22.63 Bn	684.20 Mn
10	Elutia	40.75 Mn	20.85 Mn	1.45 Mn

Download Data